Adam de Havenon, MD, MSCI
Associate Professor TermCards
About
Research
Overview
During vascular neurology fellowship training, I discovered that I want the expertise to successfully fill the space between the basic science of stroke research and its implementation in human subjects. My long-term research goal is to bridge these fields and lead a team of basic and clinical researchers to address the most treatment-resistant diseases in vascular neurology and to provide excellent care to patients suffering from these diseases. I have consistently obtained competitive grant awards, including a K23, R01, and UG3/UH3 from NIH/NINDS. In 2021, I finished a Masters of Science in Clinical Investigation degree. I am the principal investigator of the observational trial in my K23, the multicenter BP-VISO study, and the StrokeNet study CAPTIVA-MRI. At my prior institution, I established the de Havenon Lab and mentees in my lab received a number of research awards and scholarships, including an NIH NRS training grant and an American Academy of Neurology Medical Student Research Scholarship. In 2022, we established the de Havenon lab at Yale and have been expanding its footprint. The lab's goal is to advance research that will benefit patients with stroke and to help train the next generation of cerebrovascular researchers.
Clinical Care
Overview
Adam de Havenon, MD, is a vascular neurologist who primarily treats patients with stroke, but also cares for patients with vascular malformations, aneurysms, and a variety of other neurological diseases including cerebral amyloid angiopathy.
“I was always interested in the brain, and I knew in medical school that I wanted to be a neurologist,” Dr. de Havenon says. “During my general neurology residency, I was drawn to the ability to effectively treat patients with stroke, as well as the fact that stroke is such a common disease, allowing you to have an impact on many patients.” As the field evolved, he trained to be able treat complicated stroke cases.
“Even in the 10 years or so I’ve been practicing, there have been so many developments,” Dr. de Havenon says. Treatments for acute, ischemic, and hemorrhagic stroke have been evolving so rapidly that “we’re able to offer interventions to improve outcomes for patients that we couldn’t do even three years ago.”
But it’s also important for anyone who is experiencing symptoms of stroke to get to the hospital as quickly as possible so treatments can be administered, he says. People should call 9-1-1 right away if they notice sudden symptoms including numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion; trouble seeing or walking; or severe headache with no known cause.
Dr. de Havenon says his clinical work and research overlap in that he typically treats similar patients in both areas. He is especially interested in intracranial atherosclerosis, vascular cognitive impairment, and stroke in people younger than 50. “Essentially, I think of it as stroke prevention research,” he says. “What I am trying to find out is how to prevent future strokes and improve the quality of life for my patients.”
Clinical Specialties
Fact Sheets
Carotid Artery Disease Imaging
Learn More on Yale MedicineStroke
Learn More on Yale MedicineIschemic Stroke
Learn More on Yale MedicineDizziness
Learn More on Yale Medicine
Board Certifications
Vascular Neurology
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2014
Neurology
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2013